Navigation Links
AMPLICOR HIV-1 Monitor Test, v1.5

ProductsAMPLICOR HIV-1 Monitor Test, v1.5
Company Roche Diagnostics
Item AMPLICOR HIV-1 Monitor Test, v1.5
Features 
  • High levels of sensitivity for an accurate measurement of viral suppression in patients on anti-retroviral therapy
  • 100% specificity
  • A domain of linearity from 50 to 750,000 copies/mL1
  • Proven performance in major pharmaceutical studies
  • The only FDA-approved test which can measure HIV-1 RNA down to 50 copies/mL
  • Quantification of HIV-1 Group M subtypes A-G
Description The AMPLICOR HIV-1 MONITOR Test, v1.5, an FDA-approved HIV-1 RNA assay, is utilized for HIV-1 viral load testing, has been used in the regulatory approval for HIV-1 therapies, and is now found in eight out of 10 clinical laboratories worldwide.

The AMPLICOR HIV-1 MONITOR Test, v1.5 is an in vitro nucleic acid amplification test for the quantification of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in human plasma. The test can be used to assess patient prognosis by measuring the baseline HIV-1 RNA level and to monitor the effects of anti-retroviral therapy by measuring changes in plasma HIV-1 RNA levels during the course of anti-retroviral treatment.

The Gold Standard in Viral Load Assessment

The AMPLICOR HIV-1 MONITOR Test was the first commercial FDA-approved test to quantify the amount of HIV-1 RNA. This test has been used for FDA approval of most of the currently approved anti-retroviral drugs. With a limited number of treatment regimens available to HIV-1 patients, the accurate monitoring of viral load levels is essential to establish and monitor the effectiveness of therapeutic regimens, assess the potential of drug resistance and identify treatment failure.

Info Roche DiagnosticsCall Roche Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-415-6694

Customer Service: 1-800-428-5074
Web site: http://www.roche-diagnostics.com

Related medicine products :

1. OraSure HIV-1 Oral Specimen Collection Device
2. OraQuick ADVANCE Rapid HIV-1/2 Antibody Test
3. Reveal Rapid HIV-1 Antibody Test
4. Vironostika HIV-1 Plus O Microelisa System
5. Genetic Systems HIV-1/HIV-2 Peptide EIA
6. ViroSeq HIV-1 Genotyping System
7. Procleix HIV-1/HCV Assay
8. NucliSens HIV-1 QT
9. OraSure HIV-1 Western Blo
10. Genetic Systems HIV-1 Western Blot
11. Cambridge Biotech HIV-1 (Western Blot)
... Pipetman Ultra is a fully adjustable, air-displacement ... It is the latest member of the ... characteristics: robustness, accuracy, and precision. We also ... feedback from our customers. Eight models cover ...
... cover the range from 2ul to 5000ul. ... lock design prevents inadvertent volume change. Novel ... Whole pipette is autoclavable at 121C(250F). To ... Suitable for one-handed operation. Auto or ...
... offers improved ergonomics for today's exacting ... grippy finger rest and the large ... efficiency. Finnpipette Digitals also feature soft-touch ... (pat. pend.) and super blow-out for ...
... In the specialty areas ... or intensive care work, it ... in your practice. Alokas motorized ... Doppler and Tissue Harmonic Echo ...
Medicine Products:
(Date:9/18/2014)... Kent, WA Chiropractor Danene Saggau and the ... that Dawn Kelly has agreed to become the new Office ... to Ms. Kelly expanding her role within the practice, noting ... key contributor. “ Dawn Kelly brings to the clinic ... that will allow me to focus on the patient ...
(Date:9/18/2014)... Alexandria, VA — The Public Health ... communities have joined the growing ranks of those reaping ... decisions bring the number of governmental public health departments ... non-profit organization that administers the national public health accreditation ... of the public by advancing the quality and performance ...
(Date:9/18/2014)... -- Older people become more physically vulnerable during bereavement, ... stress hormones during bereavement changes with age, British researchers ... are more likely to have weakened immune systems and ... weeks and months after loss, we can suffer from ... of white blood cell and as such are essential ...
(Date:9/18/2014)... September 18, 2014 It’s been just a ... newest, patent pending bunion splint to website visitors, but already ... wrote: "I was absolutely delighted. It is perfect and I ... am wearing them. THANK YOU FOR LISTENING!!!" Another user ... saying, "The hole used to slip to the end of ...
(Date:9/18/2014)... Alan Mozes HealthDay Reporter , ... to emergency room waiting times, patients seeking care at larger ... the clock than those seen at smaller or more rural ... our ability to provide timely emergency care varies dramatically across ... of the new research, Dr. Renee Hsia, an associate professor ...
Breaking Medicine News(10 mins):Health News:Lake Meridian Chiropractic of Kent, WA Announces that Dawn Kelly Has Been Promoted to the Position of Office Manager 2Health News:Ten More Communities Reaping Benefits of National Accreditation 2Health News:Ten More Communities Reaping Benefits of National Accreditation 3Health News:Ten More Communities Reaping Benefits of National Accreditation 4Health News:Grief Can Weigh on Immune System in Older Folks, Study Says 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:ER Waiting Times Vary Significantly, Studies Find 2Health News:ER Waiting Times Vary Significantly, Studies Find 3
... Iran: Revolution and Reproduction has been selected as this year,s ... Year of the Islamic Republic of Iran. Edited by Mohammad ... the first to attempt to explain why the fertility rate ... end of the 20th century. The prize is awarded by ...
... million deaths from cancer in Europe in 2011 according to ... Annals of Oncology today (Wednesday 9 February) [1]. ... for the first time in Europe a new mathematical model ... death rates for both men and women when compared to ...
... Scientific American MIND to present an event just in time ... what makes romantic relationships succeed or fail. The ... 2011, 7:00 PM - 8:30 PM at The New York ... City. According to Columbia University psychiatrist and neuroscientist Amir ...
... by Boston University School of Public Health (BUSPH) researchers ... help smokers quit, producing six-month abstinence rates nearly double ... study published online ahead of print in the American ... of respondents reported having quit smoking six months after ...
... TUESDAY, Feb. 8 (HealthDay News) -- Babies who are exposed ... virus have lower levels of antibodies to diseases such as ... Researchers collected serum samples from 104 HIV-infected and uninfected South ... again from 93 of the infants at 16 weeks of ...
... , TUESDAY, Feb. 8 (HealthDay News) -- In pregnant women, ... significantly higher blood pressure, new research suggests. The study ... had a lead level higher than about 1 microgram per ... lower than the safety thresholds set by the U.S Centers ...
Cached Medicine News:Health News:Researchers predict nearly 1.3 million cancer deaths in Europe in 2011 2Health News:Researchers predict nearly 1.3 million cancer deaths in Europe in 2011 3Health News:Electronic cigarettes hold promise as aid to quitting 2Health News:Mom's HIV May Lower Baby's Immunity to Other Diseases 2Health News:Lead Exposure May Raise Blood Pressure in Pregnancy 2
(Date:9/18/2014)... Sept. 18, 2014  Aratana Therapeutics, Inc. (NASDAQ: ... focused on licensing, developing and commercializing innovative biopharmaceutical ... exercise of the underwriters, option to purchase 675,000 ... the company,s previously announced public offering of 4,500,000 ... are being offered by Aratana Therapeutics.  With the ...
(Date:9/18/2014)... , Sept. 18, 2014 Research and ... Market Monitor : Global Chiral Separation Columns Market" ... chromatography is a technique involving two enantiomers of the ... consisting of a single enantiomer, thus possessing different elution ... such as cellulose. The chiral separation chromatography ...
(Date:9/18/2014)... , Sept. 18, 2014  Decision Resources ... the United States , 54 ... GlaxoSmithKline,s BRAF inhibitor Tafinlar for BRAF -mutation-positive ... who have prescribed GlaxoSmithKline,s MEK inhibitor Mekinist. Among ... percentage (42 percent and 43 percent, respectively) expects ...
Breaking Medicine Technology:Aratana Therapeutics, Inc. Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 2Micro Market Monitor: Global Chiral Separation Columns Market 2At One Year Post-Launch, Approximately One Half of Surveyed U.S. Medical Oncologists Have Prescribed Single-Agent Tafinlar and Mekinist to Their Malignant Melanoma Patients 2